Iron Oxide Nanoparticles Functionalized With Macrocycle Antagonists for CXCR4 Receptor Targeting in Cancer Cells. J. Anal. Oncol. 2024, 13, 36-42. https://doi.org/10.30683/1927-7229.2024.13.06.